World's Best Scientists 2026 revealed!
Award Badge
Medicine
Netherlands
2023
Award Badge
Microbiology
Netherlands
2022

D-Index & Metrics

Microbiology

D-Index
98
Citations
32993
World Ranking
459
National Ranking
32

Medicine

D-Index
109
Citations
43889
World Ranking
5781
National Ranking
216

Charles A. Boucher publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Charles A. Boucher sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 405 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Charles A. Boucher D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Charles A. Boucher sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 98 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Netherlands Leader Award
  • 2022 - Research.com Microbiology in Netherlands Leader Award

Overview

Charles A. Boucher was affiliated with Erasmus University Rotterdam in the Netherlands. Their research spanned primarily medicine and immunology and microbiology, with a focus on infectious diseases, epidemiology, virology, molecular biology, and hepatology.

The scientist contributed to fields related to viral infections and immune response mechanisms, concentrating notably on HIV/AIDS and hepatitis research as well as SARS-CoV-2 and COVID-19. Their main topics of work included:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • Hepatitis B Virus Studies
  • HIV, Drug Use, Sexual Risk
  • Hepatitis C virus research
  • SARS-CoV-2 and COVID-19 Research

Charles A. Boucher published extensively, with recent papers demonstrating involvement in studies on infectious virus shedding, liver organoids for HBV infection, selective death of HIV-1-infected cells, and quality of life assessments among people living with HIV. Notable publications included:

  • "Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)," 2021, Nature Communications
  • "Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants," 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • "Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma," 2021, eLife
  • "Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir," 2021, Nature Communications
  • "Quality of life among people living with HIV in England and the Netherlands: a population-based study," 2021, The Lancet Regional Health - Europe

Their research appeared frequently in several publication venues, including:

  • Viruses
  • Clinical Infectious Diseases
  • Nature Communications
  • bioRxiv (Cold Spring Harbor Laboratory)
  • AIDS Research and Human Retroviruses

Collaboration played a significant role in their work. Frequent co-authors included:

  • David van de Vijver
  • Annelies Verbon
  • Casper Rokx
  • Jeroen J. A. van Kampen
  • Stephanie Popping

Best Publications

  • Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

    Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes

  • Ordered accumulation of mutations in HIV protease confers resistance to ritonavir.

    Molla A;Korneyeva M;Gao Q;Vasavanonda S

  • Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery

    K.A. Eagle;C.M. Coley;J.B. Newell;D.C. Brewster

  • Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery.

    C A Boucher;D C Brewster;R C Darling;R D Okada

  • Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

    J. Durant;P. Clevenbergh;P. Halfon;P. Delgiudice

  • Technetium-99m Hexakis 2-Methoxyisobutyl Isonitrile: Human Biodistribution, Dosimetry, Safety, and Preliminary Comparison to Thallium-201 for Myocardial Perfusion Imaging

    F J Wackers;D S Berman;J Maddahi;D D Watson

  • Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets

    Vincent J. Munster;Emmie de Wit;Judith M. A. van den Brand;Sander Herfst

  • Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).

    Jeroen J. A. van Kampen;David A. M. C. van de Vijver;Pieter L. A. Fraaij;Bart L. Haagmans

  • A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE

    Sven A. Danner;Andrew Carr;John M. Leonard;Leah M. Lehman

  • Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)

    Rob Schuurman;Monique Nijhuis;Remko van Leeuwen;Pauline Schipper

  • Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.

    N K Back;M Nijhuis;W Keulen;C A Boucher

  • An automated genotyping system for analysis of HIV-1 and other microbial sequences

    Tulio De Oliveira;Koen Deforche;Sharon Cassol;Mika Salminen

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine.

    Paul Kellam;Charles A. B. Boucher;Brendan A. Larder

  • Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.

    Monique Nijhuis;Rob Schuurman;Dorien de Jong;John Erickson

  • T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).

    M. D. Hazenberg;J. W. T. C. Stuart;S. A. Otto;J. C. C. Borleffs

  • Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.

    Charles A. B. Boucher;Eithne O'Sullivan;Jan W. Mulder;Chitra Ramautarsing

  • Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection.

    M. D. Hazenberg;S. A. Otto;J. W. Cohen Stuart;M. C. Verschuren

  • High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase.

    C. A. B. Boucher;N. Cammack;P. Schipper;R. Schuurman

  • Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

    Cristina Tural;Lidia Ruiz;Christopher Holtzer;Jonathan Schapiro

Frequent Co-Authors

H. William Strauss
H. William Strauss Cornell University
Gerald M. Pohost
Gerald M. Pohost University of Southern California
David A. M. C. van de Vijver
David A. M. C. van de Vijver Erasmus University Rotterdam
Rob Schuurman
Rob Schuurman Utrecht University
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Jan Albert
Jan Albert Karolinska Institute
Jaap Goudsmit
Jaap Goudsmit Harvard University
Annemarie M. J. Wensing
Annemarie M. J. Wensing Utrecht University
Peter C. Block
Peter C. Block Emory University
Martin Schutten
Martin Schutten Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various online degrees and career paths that complement this field. For example, becoming a child life specialist salary professional can be a rewarding avenue, combining health science knowledge with patient interaction skills.

Individuals with diverse backgrounds, including those who wonder what can a felon go to college for, can explore microbiology-related programs online. Many colleges offer flexible admissions policies and tailored support to help students overcome barriers and succeed.

Another growing field linked to microbiology is functional medicine nursing. The functional medicine np salary reflects the increasing demand for holistic medical practitioners skilled in microbiological and biochemical knowledge.

Additionally, careers in healthcare administration, such as medical coding, are crucial for healthcare systems. Understanding cpc medical coding salary can illustrate how certification in this area complements science degrees and leads to stable job opportunities.

Best Scientists Citing Charles A. Boucher

Recently Published Articles